U

University of Miami | Schiff Center For Liver Diseases

Research site

(Unclaimed)

Location

1500 NW 12th Avenue, Suite 1101-E, Miami, Florida, United States of America

Site insights

Top conditions

Top treatments

Daclatasvir

BMS-650032

BMS-790052

Lanifibranor

Ribavirin

BMS-986263

pegInterferon

Mangoral

Obeticholic Acid

Ursodeoxycholic Acid

Parent organization

This site is a part of University of Miami

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 11 total trials

A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( NATiV3 )

This Phase 3 study is conducted to evaluate lanifibranor in adults with NASH and liver fibrosis histological stage F2 or F3

Enrolling

NASH - Nonalcoholic Steatohepatitis

Drug: Placebo

Drug: IVA337

A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Biliary Cholangitis (VANTAGE)

The purpose of this clinical research study is to learn more about the use of the study medicine, volixibat, for the treatment of pruritus (itching)...

Enrolling

PBC

Primary Biliary Cholangitis

Drug: Placebo

Drug: Volixibat

Trial sponsors

A

H

I

T

Clinical trials

Find clinical trials Trials by location

Research sites

Find research sites Learn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy Notice Terms